Health Care & Life Sciences » Pharmaceuticals | Jacobson Pharma Corp. Ltd.

Jacobson Pharma Corp. Ltd. | Income Statement

Fiscal year is April-March. All values HKD Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
926
948
1,084
1,256
1,549
1,705
Cost of Goods Sold (COGS) incl. D&A
514
580
617
699
931
1,015
Gross Income
412
368
467
557
618
690
SG&A Expense
254
235
272
333
339
351
EBIT
158
133
195
224
278
339
Unusual Expense
-
-
9
-
13
24
Non Operating Income/Expense
62
3
4
10
2
9
Interest Expense
6
3
3
14
46
66
Pretax Income
217
136
183
221
251
315
Income Tax
32
22
30
40
46
56
Consolidated Net Income
185
114
153
181
205
259
Net Income
172
102
146
179
202
251
Net Income After Extraordinaries
172
102
146
179
202
251
Net Income Available to Common
172
102
146
179
202
251
EPS (Basic)
0.10
0.06
0.08
0.11
0.11
0.13
Basic Shares Outstanding
1,750
1,750
1,750
1,574
1,816
1,931
EPS (Diluted)
0.10
0.06
0.08
0.11
0.11
0.13
Diluted Shares Outstanding
1,750
1,750
1,750
1,575
1,816
1,931
EBITDA
202
186
265
305
391
453
Non-Operating Interest Income
3
3
3
2
4
5
Minority Interest Expense
12
12
7
2
3
8

About Jacobson Pharma Corp.

View Profile
Address
Unit 2313-18, 23/F
Hong Kong
Hong Kong
Employees -
Website http://www.jacobsonpharma.com
Updated 07/08/2019
Jacobson Pharma Corp. Ltd. engages in the provision of generic drugs for both public and private sectors. It operates through the following segments: Generic Drugs, Proprietary Medicines, and Wholesale and Retal. The Generic Drugs segment develops, manufactures and distributes a host of off-patent medicines for various therapeutic use.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.